|22nd April 2020||Arthur S Leibowitz||18,564||Grant/award etc.||$0.00|
|22nd April 2020||Timothy M. Cunningham||27,847||Grant/award etc.||$0.00|
|22nd April 2020||Gary S. Gillheeney||88,181||Grant/award etc.||$0.00|
|22nd April 2020||Wayne D Mackie||18,564||Grant/award etc.||$0.00|
|22nd April 2020||Lori Freedman||26,918||Grant/award etc.||$0.00|
|22nd April 2020||Patrick Bilbo||34,035||Grant/award etc.||$0.00|
|22nd April 2020||Antonio S. Montecalvo||24,134||Grant/award etc.||$0.00|
|22nd April 2020||Brian Grow||32,488||Grant/award etc.||$0.00|
|22nd April 2020||Joshua Alexander Tamaroff||18,564||Grant/award etc.||$0.00|
|14th April 2020||Brian Grow||1,150||Exercise of derivative||$1.70||$1,955.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Organogenesis Holdings, Inc. focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.